Literature DB >> 12570330

Environment-gene interactions in intestinal cancer.

Leonard H Augenlicht1, Barbara G Heerdt, John M Mariadason, WanCai Yang, Andrew J Wilson, Alessandra Fragale, Anna Velcich.   

Abstract

Only 5-10% of all colorectal cancer in the United States can be directly attributed to inheritance of genetic predisposition for tumor development. Thus, the vast majority of colorectal cancer is classified as sporadic, and in these patients environmental factors--particularly the diet--play a major role in determining the probability of tumor formation and its progression. Investigations of how dietary components interact with genetic factors in cancer development have been extremely productive in terms of understanding the subtle and complex mechanisms that maintain homeostasis of the intestinal mucosa, and how perturbations in these mechanisms cause disease. We have found that the cyclin-dependent kinase inhibitor p21(WAF1/cip1) plays a major role in regulating several aspects of mucosal homeostasis and the response to dietary and pharmacologic modulators of tumorigenesis; that disruption of lineages of differentiation of intestinal epithelial cells are intimately involved in tumor formation; and that important pathways that contribute to normal homeostasis and cancer development may be coordinately regulated by mitochondrial function, with the mitochondrial membrane potential playing a key role. Several lines of evidence from our work have also suggested that intestinal epithelial cells have adapted to the environment that they usually encounter. This renders the cells competent to efficiently utilize factors in the intestinal lumen in normal metabolic and signaling pathways that contribute to homeostasis.

Entities:  

Mesh:

Year:  2002        PMID: 12570330

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  7 in total

1.  Loss of JNK2 increases intestinal tumor susceptibility in Apc1638+/- mice with dietary modulation.

Authors:  Xiuli Bi; Nicole M Pohl; Zhinan Yin; Wancai Yang
Journal:  Carcinogenesis       Date:  2010-12-23       Impact factor: 4.944

2.  Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer.

Authors:  Lin Cai; Zong-Li Zheng; Zuo-Feng Zhang
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

3.  Role of serum polyunsaturated fatty acids in the development of colorectal cancer.

Authors:  Pengjun Zhang; Xinyu Wen; Feng Gu; Xinsheng Zhang; Juan Li; Yulan Liu; Jin Dong; Xinxin Deng; Xu Zhu; Yaping Tian
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Nutritional-pharmacological combinations--a novel approach to reducing colon cancer incidence.

Authors:  Betty Schwartz; Yehudit Birk; Amiram Raz; Zecharia Madar
Journal:  Eur J Nutr       Date:  2004-01-06       Impact factor: 5.614

5.  A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma.

Authors:  Lei Cao; Jia Lin; Bing He; Hongge Wang; Juan Rao; Yingwen Liu; Xuemei Zhang
Journal:  Tumour Biol       Date:  2013-08-11

6.  A genetic variant of miR-148a binding site in the SCRN1 3'-UTR is associated with susceptibility and prognosis of gastric cancer.

Authors:  Peng Song; Haixia Zhu; Dong Zhang; Haiyan Chu; Dongmei Wu; Meiyun Kang; Meilin Wang; Weida Gong; Jianwei Zhou; Zhengdong Zhang; Qinghong Zhao
Journal:  Sci Rep       Date:  2014-11-17       Impact factor: 4.379

7.  Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.

Authors:  Jin Feng; Xiaolin Pan; Junbo Yu; Zheng Chen; Hao Xu; Wael El-Rifai; Guoxin Zhang; Zekuan Xu
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.